Pinned Repositories
3Drendering-NoEcho
CancerTreatmentCharacterization
Covid19CharacterizationCharybdis
Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2 (CHARYBDIS) - a study to describe the baseline demographic, clinical characteristics, treatments and outcomes of interest among individuals tested for SARS-CoV-2 and/or diagnosed with COVID-19 compared to Influenza patients from 2017-2018
github-slideshow
A robot powered training repository :robot:
merge-conflicts
MusculoskeletalAEsAfterAIs
A Cohort Diagnostics study to determine the feasibility of progressing to a Population level estimate (PLE) cohort study using non-identifiable data mapped to the OHDSI Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to evaluate the risk of adverse musculoskeletal events in post-menopausal women taking AI compared to tamoxifen to treat breast cancer.
OHDSICancerRegimens
a study characterizing the treatments of cancer patients
PCE
Network study validating the Pooled Cohort Equation Model
RanitidineCancerRisk
RanitidineCancerRisk
RCRI
Study that evaluates the RCRI model on any data in the OMOP CDM
tfalcs's Repositories
tfalcs/3Drendering-NoEcho
tfalcs/CancerTreatmentCharacterization
tfalcs/Covid19CharacterizationCharybdis
Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2 (CHARYBDIS) - a study to describe the baseline demographic, clinical characteristics, treatments and outcomes of interest among individuals tested for SARS-CoV-2 and/or diagnosed with COVID-19 compared to Influenza patients from 2017-2018
tfalcs/github-slideshow
A robot powered training repository :robot:
tfalcs/merge-conflicts
tfalcs/MusculoskeletalAEsAfterAIs
A Cohort Diagnostics study to determine the feasibility of progressing to a Population level estimate (PLE) cohort study using non-identifiable data mapped to the OHDSI Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to evaluate the risk of adverse musculoskeletal events in post-menopausal women taking AI compared to tamoxifen to treat breast cancer.
tfalcs/OHDSICancerRegimens
a study characterizing the treatments of cancer patients
tfalcs/PCE
Network study validating the Pooled Cohort Equation Model
tfalcs/RanitidineCancerRisk
RanitidineCancerRisk
tfalcs/RCRI
Study that evaluates the RCRI model on any data in the OMOP CDM
tfalcs/ScyllaEstimation
tfalcs/SedativesStudy
treatment pattern characterisation of hypnotics and sedatives